New Brunswick, NJ (May 19, 2011) – Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceuticals business for the investment community beginning at 9:00 a.m. (Eastern Time) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J. ending at approximately 3:00 p.m.
Sheri McCoy, Vice Chairman, Executive Committee, and Pharmaceuticals Worldwide Chairmen Joaquin Duato and Paul Stoffels, M.D. will host the meeting and discuss the role the segment plays in the Company’s overall business and growth strategy. The meeting will also feature presentations from the five therapeutic area leaders in the Pharmaceuticals research and development organization.
Investors and other interested parties may access this meeting by visiting the Company’s website at www.investor.jnj.com for a simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com .
###
Press Contacts:
Bill Price
(732) 524-6623
(732) 668-3735 (M)
Carol Goodrich
(732) 524-6678
(973) 615-4057 (M)
Investor Contacts:
Louise Mehrotra
(732) 524-6491
Stan Panasewicz
(732) 524-2524